BACKGROUND AND PURPOSE: Niemann-Pick disease type C (NPC) is a progressive neurovisceral disorder associated with dystonia, ataxia and a characteristic gaze palsy. Neuropathological studies have demonstrated brainstem atrophy associated with neuronal inclusions and loss, and neurofibrillary tangles, although it is not known whether this pathology can be detected in vivo or how these changes relate to illness variables, particularly ocular-motor changes. Our aim was to utilize a method for brainstem atrophy, validated in progressive supranuclear palsy (PSP), in a group of adult patients with NPC, and explore its relationship to illness variables and ocular-motor functioning. METHODS: We calculated the midbrain and pontine area, and pontine-to-midbrain ratio (PMR) from midsagittal images of 10 adult patients with NPC and 27 age- and gender-matched controls. Measures were correlated with illness variables, and measures of horizontal saccadic functioning. RESULTS: Pontine-to-midbrain ratio was 14% higher in the NPC group, but this difference was not significant. However, PMR showed a significant positive correlation with duration of illness and a measure of illness severity. Furthermore, PMR was significantly negatively correlated with saccadic peak velocity and gain, and self-paced saccadic performance. CONCLUSIONS: Pontine-to-midbrain ratio was increased in adult patients with NPC compared to controls, although not to the same degree as previously described in PSP, which also presents with significant gaze palsy. These changes were driven predominantly by progressive midbrain atrophy. The strong correlation with illness and ocular-motor variables suggests that it may be a useful marker for illness progression in NPC.
BACKGROUND AND PURPOSE:Niemann-Pick disease type C (NPC) is a progressive neurovisceral disorder associated with dystonia, ataxia and a characteristic gaze palsy. Neuropathological studies have demonstrated brainstem atrophy associated with neuronal inclusions and loss, and neurofibrillary tangles, although it is not known whether this pathology can be detected in vivo or how these changes relate to illness variables, particularly ocular-motor changes. Our aim was to utilize a method for brainstem atrophy, validated in progressive supranuclear palsy (PSP), in a group of adult patients with NPC, and explore its relationship to illness variables and ocular-motor functioning. METHODS: We calculated the midbrain and pontine area, and pontine-to-midbrain ratio (PMR) from midsagittal images of 10 adult patients with NPC and 27 age- and gender-matched controls. Measures were correlated with illness variables, and measures of horizontal saccadic functioning. RESULTS: Pontine-to-midbrain ratio was 14% higher in the NPC group, but this difference was not significant. However, PMR showed a significant positive correlation with duration of illness and a measure of illness severity. Furthermore, PMR was significantly negatively correlated with saccadic peak velocity and gain, and self-paced saccadic performance. CONCLUSIONS: Pontine-to-midbrain ratio was increased in adult patients with NPC compared to controls, although not to the same degree as previously described in PSP, which also presents with significant gaze palsy. These changes were driven predominantly by progressive midbrain atrophy. The strong correlation with illness and ocular-motor variables suggests that it may be a useful marker for illness progression in NPC.
Authors: Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang Journal: CNS Drugs Date: 2019-02 Impact factor: 5.749
Authors: Elizabeth A Bowman; Mark Walterfang; Larry Abel; Patricia Desmond; Michael Fahey; Dennis Velakoulis Journal: J Neurol Date: 2015-06-20 Impact factor: 4.849
Authors: Jeffrey Cl Looi; Dennis Velakoulis; Mark Walterfang; Nellie Georgiou-Karistianis; Matthew D Macfarlane; Brian D Power; Christer Nilsson; Martin Styner; Paul M Thompson; Danielle Van Westen; Fiona A Wilkes; Lars-Olof Wahlund Journal: Australas Psychiatry Date: 2014-02-19 Impact factor: 1.369
Authors: Thomas Kirkegaard; James Gray; David A Priestman; Kerri-Lee Wallom; Jennifer Atkins; Ole Dines Olsen; Alexander Klein; Svetlana Drndarski; Nikolaj H T Petersen; Linda Ingemann; David A Smith; Lauren Morris; Claus Bornæs; Signe Humle Jørgensen; Ian Williams; Anders Hinsby; Christoph Arenz; David Begley; Marja Jäättelä; Frances M Platt Journal: Sci Transl Med Date: 2016-09-07 Impact factor: 17.956
Authors: Marc C Patterson; Eugen Mengel; Frits A Wijburg; Audrey Muller; Barbara Schwierin; Harir Drevon; Marie T Vanier; Mercé Pineda Journal: Orphanet J Rare Dis Date: 2013-01-16 Impact factor: 4.123
Authors: Larry A Abel; Elizabeth A Bowman; Dennis Velakoulis; Michael C Fahey; Patricia Desmond; Matthew D Macfarlane; Jeffrey Chee Leong Looi; Christopher L Adamson; Mark Walterfang Journal: PLoS One Date: 2012-11-30 Impact factor: 3.240